Annual report [Section 13 and 15(d), not S-K Item 405]

Convertible Instruments and Accrued Interest (Tables)

v3.25.2
Convertible Instruments and Accrued Interest (Tables)
12 Months Ended
May 31, 2025
Convertible Instruments and Accrued Interest  
Schedule of information on dividends of convertible preferred stock

May 31, 2025

May 31, 2024

(in thousands except conversion rate)

    

Series B

    

Series C

    

Series D

    

Series B

    

Series C

    

Series D

Shares of preferred stock outstanding

19

6

9

19

6

9

Common stock conversion rate

10:1

2,000:1

1,250:1

10:1

2,000:1

1,250:1

Total shares of common stock if converted

190

12,670

10,565

190

12,670

10,565

Undeclared dividends

$

24

$

$

$

19

$

$

Accrued dividends

$

$

3,769

$

4,500

$

$

3,135

$

3,656

Total shares of common stock if dividends converted

48

7,538

9,000

38

6,270

7,312

Schedule of outstanding balances of convertible notes and accrued interest

May 31, 2025

May 31, 2024

(in thousands)

    

April 2, 2021 Note

    

April 23, 2021 Note

    

Total

    

April 2, 2021 Note

    

April 23, 2021 Note

Total

Convertible notes payable outstanding principal

$

2,831

$

24,369

$

27,200

$

2,831

$

27,369

$

30,200

Less: Unamortized debt discount and issuance costs

(45)

(362)

(407)

Convertible notes payable, net

2,831

24,369

27,200

2,786

27,007

29,793

Accrued interest on convertible notes

5,378

12,773

18,151

4,634

10,593

15,227

Outstanding convertible notes payable, net and accrued interest

$

8,209

$

37,142

$

45,351

$

7,420

$

37,600

$

45,020

Schedule of changes to outstanding balance of convertible notes, including accrued interest

(in thousands)

April 2, 2021 Note

April 23, 2021 Note

Total

Outstanding balance at May 31, 2024

$

7,420

$

37,600

$

45,020

Amortization of issuance discount and costs

45

362

407

Interest expense

744

3,680

4,424

Fair market value of shares and warrants exchanged for repayment

(4,273)

(4,273)

Difference between market value of
common shares and reduction of principal

(227)

(227)

Outstanding balance at May 31, 2025

$

8,209

$

37,142

$

45,351